BackgroundShort-term outcomes using navigated surgery reduced surgical time, blood loss, intralesional resection rate and preserved function.AimsWe investigated the local recurrence rate at extended follow-up in patients following navigated resection of primary pelvic and sacral tumours.MethodsThis prospective cohort study comprised 23 consecutive patients between 2010and 2012 undergoing primary pelvic and sacral tumour resection using computer navigation. Local recurrence (LR) and mortality rates were calculatedusing the Kaplan-Meier method.ResultsBone resection margins were all clear, with no bony recurrence. At a medianfollow-up of 6.0 years, eight patients (34.8%) developed soft-tissue LR with anoverall cumulative LR rate at 6-years of ...
SummaryIntroductionChondrosarcoma (CS) is a primary malignant bone tumor with cartilaginous differen...
Purpose: To compare the ability of margin classification systems to determine local recurrence (LR...
Background: Chondrosarcoma is the second most frequent primary malignant bone tumor. Treatment is ma...
Background Anatomic and surgical complexity make pelvic and sacral bone sarcoma resections challengi...
BACKGROUND: Limb salvage surgery for pelvic bone sarcoma carries a very high risk of local recurrenc...
Introduction: The rates of cure for pelvic tumours are still lower compared to tumours involving the...
Introduction: Safe surgical margins are difficult to achieve when performing surgical resections f...
Purpose Chordoma is a rare but highly aggressive primary bone sarcoma that arises commonly from the ...
AbstractBackgroundThe incidence of rectal cancer recurrence after surgery is 5–45%. Extended pelvic ...
Introduction: Safe surgical margins are difficult to achieve when performing surgical resections for...
Objectives Survival in patients with chondrosarcomas has not improved over 40 years. Although emergi...
none5Background The treatment of choice in sacral chordoma is surgical resection, although the ri...
Background: Safe surgical margins are difficult to achieve when performing surgical resections for b...
Aims The purpose of this study was to investigate the potential for achieving local and systemic con...
SummaryIntroductionPelvic primary malignant bone tumours, especially when involving the sacroiliac j...
SummaryIntroductionChondrosarcoma (CS) is a primary malignant bone tumor with cartilaginous differen...
Purpose: To compare the ability of margin classification systems to determine local recurrence (LR...
Background: Chondrosarcoma is the second most frequent primary malignant bone tumor. Treatment is ma...
Background Anatomic and surgical complexity make pelvic and sacral bone sarcoma resections challengi...
BACKGROUND: Limb salvage surgery for pelvic bone sarcoma carries a very high risk of local recurrenc...
Introduction: The rates of cure for pelvic tumours are still lower compared to tumours involving the...
Introduction: Safe surgical margins are difficult to achieve when performing surgical resections f...
Purpose Chordoma is a rare but highly aggressive primary bone sarcoma that arises commonly from the ...
AbstractBackgroundThe incidence of rectal cancer recurrence after surgery is 5–45%. Extended pelvic ...
Introduction: Safe surgical margins are difficult to achieve when performing surgical resections for...
Objectives Survival in patients with chondrosarcomas has not improved over 40 years. Although emergi...
none5Background The treatment of choice in sacral chordoma is surgical resection, although the ri...
Background: Safe surgical margins are difficult to achieve when performing surgical resections for b...
Aims The purpose of this study was to investigate the potential for achieving local and systemic con...
SummaryIntroductionPelvic primary malignant bone tumours, especially when involving the sacroiliac j...
SummaryIntroductionChondrosarcoma (CS) is a primary malignant bone tumor with cartilaginous differen...
Purpose: To compare the ability of margin classification systems to determine local recurrence (LR...
Background: Chondrosarcoma is the second most frequent primary malignant bone tumor. Treatment is ma...